TNFSF10 and Hepatic fibrosis: Exploiting HA-R/CD44 for liver targeting, Yang et al. developed a conjugate of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and HA (HA-TRAIL) to treat liver fibrosis.